Coagulation Pathways, Hemostasis, and Thrombosis in Liver Failure

Area of Science:

• Hepatology
• Hematology
• Critical Care Medicine

Background:

• Critically ill patients with liver failure present significant challenges in managing hemostasis.
• Uncontrolled bleeding, particularly in decompensated cirrhosis and acute-on-chronic liver failure, is a common clinical issue.
• Bleeding is categorized into portal hypertension-related and hemostatic pathway-dependent types, often coexisting with thrombosis.

Purpose of the Study:

• To outline the core elements of managing hemostasis in critically ill patients with liver failure.
• To differentiate between pressure-driven and hemostatic system-related bleeding.
• To emphasize the role of laboratory measurements in guiding clinical decisions.

Main Methods:

• Review of hemostatic management strategies in liver failure.
• Classification of bleeding types based on underlying mechanisms.
• Integration of laboratory coagulation assessments into clinical decision-making.

Main Results:

• Hemostasis management requires addressing bleeding, preventing thrombosis, and utilizing laboratory measurements.
• Liver failure profoundly disrupts coagulation and fibrinolytic systems, leading to complex bleeding disorders.
• Imbalances in hemostasis can coexist with inappropriate thrombosis, such as portal vein thrombosis.

Conclusions:

• Effective management of liver failure necessitates a comprehensive approach to hemostasis, encompassing bleeding control and thrombosis prevention.
• Laboratory monitoring of coagulation pathways is crucial for prognostic scoring and guiding interventions.
• Understanding the dual nature of bleeding and thrombosis in liver failure is key for optimal patient outcomes.